Bridgeway Capital Management’s MediciNova MNOV Stock Holding History

Bridgeway Capital Management’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$76.8K	Sell	56,031 -20,000	-26%	-$30.3K	﹤0.01%	1158
2025 Q4	$99.6K	Hold	76,031	–	–	﹤0.01%	1125
2025 Q3	$95.8K	Hold	76,031	–	–	﹤0.01%	1118
2025 Q2	$99.6K	Sell	76,031 -25,000	-25%	-$35K	﹤0.01%	1073
2025 Q1	$148K	Sell	101,031 -21,016	-17%	-$37.2K	﹤0.01%	977
2024 Q4	$256K	Sell	122,047 -23,100	-16%	-$45.1K	0.01%	955
2024 Q3	$305K	Hold	145,147	–	–	0.01%	974
2024 Q2	$209K	Hold	145,147	–	–	﹤0.01%	1050
2024 Q1	$210K	Hold	145,147	–	–	﹤0.01%	1101
2023 Q4	$218K	Hold	145,147	–	–	﹤0.01%	1118
2023 Q3	$303K	Hold	145,147	–	–	0.01%	1007
2023 Q2	$334K	Hold	145,147	–	–	0.01%	1020
2023 Q1	$314K	Sell	145,147 -50,000	-26%	-$115K	0.01%	996
2022 Q4	$400K	Hold	195,147	–	–	0.01%	936
2022 Q3	$423K	Hold	195,147	–	–	0.01%	933
2022 Q2	$494K	Sell	195,147 -10,000	-5%	-$26.1K	0.01%	878
2022 Q1	$548K	Sell	205,147 -15,000	-7%	-$36.8K	0.01%	910
2021 Q4	$590K	Buy	220,147 +39,900	+22%	+$133K	0.01%	934
2021 Q3	$683K	Buy	180,247 +78,000	+76%	+$296K	0.01%	941
2021 Q2	$435K	Buy	102,247 +33,385	+48%	+$144K	0.01%	1111
2021 Q1	$348K	Buy	+68,862	New	+$401K	0.01%	1197
2019 Q2	–	Sell	-127,710	Closed	-$1.06M	–	1365
2019 Q1	$1.06M	Hold	127,710	–	–	0.01%	748
2018 Q4	$1.04M	Sell	127,710 -5,000	-4%	-$49.9K	0.01%	712
2018 Q3	$1.66M	Buy	132,710 +35,000	+36%	+$352K	0.02%	686
2018 Q2	$778K	Sell	97,710 -41,372	-30%	-$428K	0.01%	981
2018 Q1	$1.42M	Hold	139,082	–	–	0.02%	715
2017 Q4	$900K	Hold	139,082	–	–	0.01%	875
2017 Q3	$886K	Buy	139,082 +15,000	+12%	+$79.8K	0.01%	883
2017 Q2	$653K	Hold	124,082	–	–	0.01%	997
2017 Q1	$743K	Hold	124,082	–	–	0.01%	920
2016 Q4	$748K	Buy	124,082 +30,000	+32%	+$211K	0.01%	920
2016 Q3	$705K	Hold	94,082	–	–	0.01%	940
2016 Q2	$710K	Hold	94,082	–	–	0.01%	910
2016 Q1	$691K	Hold	94,082	–	–	0.01%	921
2015 Q4	$334K	Buy	94,082 +2,100	+2%	+$6.67K	0.01%	1182
2015 Q3	$261K	Buy	91,982 +25,390	+38%	+$86.7K	0.01%	1259
2015 Q2	$263K	Buy	66,592 +22,892	+52%	+$90.4K	0.01%	1289
2015 Q1	$154K	Buy	43,700 +3,700	+9%	+$13.2K	﹤0.01%	1363
2014 Q4	$122K	Hold	40,000	–	–	﹤0.01%	1372
2014 Q3	$120K	Hold	40,000	–	–	﹤0.01%	1405
2014 Q2	$81K	Hold	40,000	–	–	﹤0.01%	1407
2014 Q1	$82K	Hold	40,000	–	–	﹤0.01%	1393
2013 Q4	$86K	Hold	40,000	–	–	﹤0.01%	1362
2013 Q3	$103K	Buy	+40,000	New	+$100K	﹤0.01%	1375

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bridgeway Capital Management's MNOV Position: Q1 2026 in Review

Bridgeway Capital Management reduced its MediciNova (MNOV) stake by 26% in Q1 2026, selling an estimated $30.3K and leaving 56,031 shares worth $76.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Bridgeway Capital Management first reported a position in MNOV in Q3 2013 and has held it in 44 quarters since. The position peaked at $1.66M in Q3 2018. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

Bridgeway Capital Management held 56,031 shares of MediciNova worth $76.8K as of Q1 2026.
Bridgeway Capital Management sold 20,000 MediciNova shares in Q1 2026, an estimated $30.3K.
MediciNova made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #1158 holding.
Bridgeway Capital Management first reported a position in MediciNova in Q3 2013 and has held it in 44 quarters since.
Bridgeway Capital Management's MediciNova position peaked at $1.66M in Q3 2018.
30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.